ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Baltimore, MD, USA:

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

types range from 1% to 20% depending on the type of malignancy. In prostate cancer, 1-3% of unselected cases harbor MMR deficiency ...

Enrolling
Recurrent Prostate Cancer
Prostate Cancer
Drug: Nivolumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

A Phase 1/2a, open-label, multicenter study of intramuscular (i.m.) PRL-02 depot in participants with advanced prostate cancer....

Enrolling
Prostate Cancer
mCSPC
Drug: docetaxel infusion
Drug: PRL-02 injection

Phase 1, Phase 2

Astellas
Astellas

Towson, Maryland, United States and 13 other locations

Locations recently updated

A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate ...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: ONCT-534

Phase 1, Phase 2

Oncternal Therapeutics

Fairfax, Virginia, United States and 8 other locations

The purpose of this trial is to investigate the safety and tolerability of TAS3681, to find the maximum tolerated dose (MTD)/recommended dose of TAS3...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: TAS3681

Phase 1

Taiho Pharma
Taiho Pharma

Baltimore, Maryland, United States and 33 other locations

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Washington, District of Columbia, United States and 107 other locations

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...

Enrolling
Prostate Cancer
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Phase 4

Lantheus Medical Imaging
Lantheus Medical Imaging

Baltimore, Maryland, United States and 4 other locations

Asymptomatic patients with metastatic castrate resistant prostate cancer (mCRPC) without pain due to prostate cancer...

Enrolling
Prostate Cancer
Drug: Enzalutamide
Drug: Luteinizing hormone-releasing hormone (LHRH) analogue

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Biological: aglatimagene besadenovec

Phase 2

Candel Therapeutics

Bethesda, Maryland, United States and 22 other locations

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Washington, District of Columbia, United States and 11 other locations

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...

Active, not recruiting
Prostate Cancer
Biological: Aglatimagene besadenovec + valacyclovir
Biological: Placebo + valacyclovir

Phase 3

Candel Therapeutics

Baltimore, Maryland, United States and 72 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems